Vitreomacular Adhesion
7
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
57%
4 trials in Phase 3/4
67%
4 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (7)
Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion
Prevalence of Vitreomacular Adhesion in Patients 40 Years and Older
Assessment of Patients Treated With JETREA® for Vitreomacular Traction
A Safety and Efficacy Assessment of Resolvine for Treatment of Vitreomacular Attachment
Intravitreal Gas for Vitreomacular Adhesion
Trial of Microplasmin Intravitreal Injection for Non-Surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-007) Trial.
Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-006) Trial.